Many people require a combination of treatments ... has approved it to improve wakefulness in adults with EDS associated with ...

Find effective medications for 'Narcolepsy treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

It was a huge relief to be diagnosed with narcolepsy, because I was able to finally say this is the problem. And this is what I need to resolve the problem. Treatment has been life-changing.

Global Narcolepsy Treatment market to Grow at 5.1% CAGR ... Usage: Approved for improving wakefulness in adults with EDS due to narcolepsy or obstructive sleep apnea. Market Position: Expected ...

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Narcolepsy is a chronic sleep disorder that causes excessive daytime sleepiness and sudden sleep attacks, impacting millions globally. The disorder, which can affect both children and adults, has seen ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

and Nuvigil® (armodafinil), both of which are indicated for the treatment of Excessive Daytime Sleepiness (EDS) in adults with narcolepsy. Neuraxpharm has acquired these products in most markets ...